We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), currently valued at $1.9 billion and trading near its 52-week low, announced the results of its 2025 Annual Meeting of Stockholders, which took place ...